Significant Accounting Policies - Clinical Fees and Insurance Revenue (Details)	12 Months Ended
Dec. 31, 2021 item
Disaggregation of Revenue [Line Items]
Number of Revenue, Practical Expedients, Elected	2
Clinical Fees & Insurance Revenue
Disaggregation of Revenue [Line Items]
Practical expedients, not adjust the transaction price for any financing components	true
Practical expedients, expensed all incremental customer contract acquisition costs as incurred	true

The number of practical expedients elected.

No definition available.

Name:	piii_NumberOfRevenuePracticalExpedientsElected
Namespace Prefix:	piii_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Indicates (true false) whether practical expedient was elected to recognize incremental cost of obtaining contract as expense when incurred if amortization period would have been one year or less.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 40
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123353750&loc=SL51790836-203054

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130569-203045

+ Details

Name:	us-gaap_RevenuePracticalExpedientIncrementalCostOfObtainingContract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

- Definition

Indicates (true false) whether practical expedient was elected not to disclose amount of transaction price allocated to remaining performance obligation and explanation of expected timing of revenue recognition for reporting period presented prior to date of initial application under retrospective method.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 65
-Paragraph 1
-Subparagraph (f)(3)
-URI http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048

+ Details

Name:	us-gaap_RevenuePracticalExpedientInitialApplicationAndTransitionNondisclosureOfTransactionPriceAllocationToRemainingPerformanceObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:booleanItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_ProductOrServiceAxis=piii_HealthCareClinicalFeesInsuranceRevenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: